Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -78,307 | -58,327 | -40,790 | -22,669 | -34,786 |
| Depreciation Amortization | -2,372 | -3,192 | -1,447 | -826 | 37 |
| Accounts payable and accrued liabilities | -346 | -994 | -1,040 | -1,134 | N/A |
| Other Working Capital | -2,416 | -3,757 | -3,280 | -3,157 | 2,652 |
| Other Operating Activity | 18,613 | 15,888 | 12,590 | 10,171 | 4,916 |
| Operating Cash Flow | $-64,828 | $-50,382 | $-33,967 | $-17,615 | $-27,181 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -167,736 | -199,892 | -146,991 | -40,854 | N/A |
| PPE Investments | -2,405 | -2,179 | -2,039 | -1,072 | -1,636 |
| Other Investing Activity | 0 | 0 | 0 | 0 | -77,224 |
| Investing Cash Flow | $-170,141 | $-202,071 | $-149,030 | $-41,926 | $-78,860 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 157,712 | 157,705 | 159,099 | N/A | N/A |
| Other Financing Activity | 63,913 | 63,913 | 63,913 | 63,659 | 145,136 |
| Financing Cash Flow | $221,625 | $221,618 | $223,012 | $63,659 | $145,136 |
| Beginning Cash Position | 70,254 | 70,254 | 70,254 | 70,254 | 31,159 |
| End Cash Position | 56,910 | 39,419 | 110,269 | 74,372 | 70,254 |
| Net Cash Flow | $-13,344 | $-30,835 | $40,015 | $4,118 | $39,095 |
| Free Cash Flow | |||||
| Operating Cash Flow | -64,828 | -50,382 | -33,967 | -17,615 | -27,181 |
| Capital Expenditure | -2,405 | -2,179 | -2,039 | -1,072 | N/A |
| Free Cash Flow | -67,233 | -52,561 | -36,006 | -18,687 | -27,181 |